靶向猪链球菌自溶素ATL:结构解析及醋酸兰瑞肽抑制
该研究解析了猪链球菌2型自溶素ATL催化域1.8 Å结构,发现atl缺失降低自溶、生物膜形成、黏附及小鼠毒力。醋酸兰瑞肽MIC为512 mg/L,亚MIC浓度不抑制生长但抑制ATL活性,减轻毒力与病理,支持ATL作为抗毒力靶点。
要点
- ATL为SS2关键毒力相关自溶素,含Zn2+依赖性酰胺酶域。
- atl缺失不影响生长,但降低自溶、生物膜、黏附及小鼠毒力。
- 醋酸兰瑞肽亚MIC抑制ATL活性,减弱毒力而不抑制生长。
核心结论
- ATL是SS2关键毒力相关自溶素。
- 醋酸兰瑞肽通过抑制ATL活性减弱SS2致病性而不抑制细菌生长,支持ATL作为潜在抗毒力靶点。
研究设计与样本
- 生物信息学分析ATL结构域组织。
- 表达纯化ATL催化域并结晶,分辨率1.8 Å。
- 构建atl缺失突变体,通过自溶、生物膜、黏附及小鼠感染实验评估功能。
- 体外和体内评估醋酸兰瑞肽对细菌生长、ATL抑制及抗毒力活性。
主要发现
- ATL含细胞壁结合重复序列和C端Zn2+依赖性酰胺酶域,催化位点为His13-Glu27-His81。
- atl缺失不影响细菌生长,但降低自溶、生物膜形成、黏附及小鼠毒力。
- 醋酸兰瑞肽MIC为512 mg/L,亚MIC浓度不抑制生长。
- 醋酸兰瑞肽抑制ATL活性,降低自溶、生物膜形成、黏附、屏障穿透及细菌负荷,减轻脾脏病理。
关键数值与推荐
- 醋酸兰瑞肽对SS2的MIC为512 mg/L。
- 亚MIC浓度下醋酸兰瑞肽不抑制细菌生长。
临床怎么用
- 醋酸兰瑞肽作为抗毒力策略,可在不抑制细菌生长情况下减弱SS2致病性,为耐药背景下提供潜在辅助治疗思路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Streptococcus suis serotype 2 (SS2) is an important zoonotic pathogen that causes severe infections in pigs and humans. Bacterial autolysins play essential roles in cell-wall remodelling and virulence; however, the structural and functional characteristics of the SS2 autolysin ATL remain poorly understood. With the increasing emergence of antimicrobial resistance, anti-virulence strategies that attenuate bacterial pathogenicity without directly inhibiting growth have attracted increasing attention. METHODS: ATL domain organization was analysed bioinformatically. The catalytic domain was expressed, purified and crystallized, and its structure was determined at 1.8 Å resolution. An atl deletion mutant was generated, and ATL function was evaluated by autolysis, biofilm formation, adhesion and mouse infection assays. Lanreotide acetate was assessed for its effects on bacterial growth, ATL inhibition and anti-virulence activity in vitro and in vivo. RESULTS: ATL contains cell-wall-binding repeats and a C-terminal Zn2+-dependent amidase domain with a His13-Glu27-His81 catalytic site. Deletion of atl did not affect bacterial growth but reduced autolysis, biofilm formation, adhesion and virulence in mice. Lanreotide acetate had a minimum inhibitory concentration (MIC) of 512 mg/L and showed no growth inhibition at sub-MIC concentrations. However, it inhibited ATL activity and reduced autolysis, biofilm formation, adhesion, barrier penetration and bacterial burden, while alleviating splenic pathology. CONCLUSIONS: ATL is a key SS2 virulence-associated autolysin. Lanreotide acetate attenuates SS2 pathogenicity by inhibiting ATL activity without suppressing bacterial growth, supporting ATL as a potential anti-virulence target.
引用
- Han H, Zhang D, Zhang X, et al. Targeting autolysin ATL of Streptococcus suis: structural insights and inhibition by lanreotide acetate. J Antimicrob Chemother. 2026. PMID: 42770615. doi:10.1093/jac/dkag326
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。